| Literature DB >> 28685779 |
Xingyue Ji1, Kaili Ji, Vayou Chittavong, Bingchen Yu, Zhixiang Pan, Binghe Wang.
Abstract
One major challenge in the development of CO as a therapeutic agent is its controllable delivery in a pharmaceutically acceptable form. Herein, we describe for the first time a general chemical strategy to esterase-sensitive organic CO-prodrugs.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28685779 DOI: 10.1039/c7cc03832a
Source DB: PubMed Journal: Chem Commun (Camb) ISSN: 1359-7345 Impact factor: 6.222